Resources from the same session
LBA28 - STAR: A randomised multi-stage phase II/III trial of standard first-line therapy (sunitinib or pazopanib) comparing temporary cessation with allowing continuation, in the treatment of locally advanced and/or metastatic renal Cancer (RCC)
Presenter: Janet Brown
Session: Proffered Paper session - Genitourinary tumours, non-prostate 2
Resources:
Abstract
Slides
Webcast
LBA29 - Nivolumab in combination with alternatively scheduled ipilimumab in first-line treatment of patients with advanced renal cell carcinoma: A randomized phase II trial (PRISM)
Presenter: Naveen Vasudev
Session: Proffered Paper session - Genitourinary tumours, non-prostate 2
Resources:
Abstract
Slides
Webcast
653O - Pembrolizumab (pembro) vs placebo as adjuvant therapy for patients (pts) with renal cell carcinoma (RCC): Patient-reported outcomes (PRO) in KEYNOTE-564
Presenter: Toni Choueiri
Session: Proffered Paper session - Genitourinary tumours, non-prostate 2
Resources:
Abstract
Slides
Webcast
LBA30 - Single-dose carboplatin followed by involved-node radiotherapy as curative treatment for seminoma stage IIA/B: Efficacy results from the international multicenter phase II trial SAKK 01/10
Presenter: Alexandros Papachristofilou
Session: Proffered Paper session - Genitourinary tumours, non-prostate 2
Resources:
Abstract
Slides
Webcast
Invited Discussant LBA28, LBA29 and 653O
Presenter: Brian Rini
Session: Proffered Paper session - Genitourinary tumours, non-prostate 2
Resources:
Slides
Webcast
Q&A and live discussion
Presenter: Laurence Albiges
Session: Proffered Paper session - Genitourinary tumours, non-prostate 2
Resources:
Slides
Webcast
Invited Discussant LBA30
Presenter: Christian Kollmannsberger
Session: Proffered Paper session - Genitourinary tumours, non-prostate 2
Resources:
Slides
Webcast